Eric Benevich

Eric Benevich is a seasoned professional in the biopharmaceutical industry, currently serving as a Board Member at aTyr Pharma since December 2024 and as Chief Commercial Officer at Neurocrine Biosciences since May 2015. At Neurocrine Biosciences, the focus is on developing innovative treatments for neurological and neuropsychiatric disorders. Prior experience includes holding roles as Vice President of Marketing at Avanir Pharmaceuticals from July 2005 to May 2015, Senior Director of Marketing at Peninsula Pharmaceuticals for the first half of 2005, and Associate Director of Marketing at Amgen from October 1999 to January 2005. Eric Benevich holds a Bachelor of Science degree in International Business from Washington State University and participated in the DIS program at Københavns Universitet - University of Copenhagen.